Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
77M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
4.51M
-
Shares change
-
-1.5M
-
Total reported value, excl. options
-
$4.38M
-
Value change
-
-$1.79M
-
Number of buys
-
15
-
Number of sells
-
-31
-
Price
-
$0.97
Significant Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q2 2019
61 filings reported holding CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value as of Q2 2019.
Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.51M shares
of 77M outstanding shares and own 5.85% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (924K shares), BlackRock Inc. (576K shares), MILLENNIUM MANAGEMENT LLC (495K shares), NORTHERN TRUST CORP (295K shares), GEODE CAPITAL MANAGEMENT, LLC (246K shares), SIGNATUREFD, LLC (184K shares), FIRST MANHATTAN CO (175K shares), Tekla Capital Management LLC (165K shares), GSA CAPITAL PARTNERS LLP (127K shares), and Paloma Partners Management Co (126K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.